Detalhe da pesquisa
1.
Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity.
Immunity
; 53(5): 925-933.e4, 2020 11 17.
Artigo
Inglês
| MEDLINE | ID: mdl-33129373
2.
Ibritumomab consolidation after 3 cycles of CHOP plus radiotherapy in high-risk limited-stage aggressive B-cell lymphoma: SWOG S0313.
Blood
; 125(2): 236-41, 2015 Jan 08.
Artigo
Inglês
| MEDLINE | ID: mdl-25395425
3.
Phase 2 study of imexon, a prooxidant molecule, in relapsed and refractory B-cell non-Hodgkin lymphoma.
Blood
; 124(8): 1259-65, 2014 Aug 21.
Artigo
Inglês
| MEDLINE | ID: mdl-25016003
4.
Genetic polymorphisms in oxidative stress-related genes are associated with outcomes following treatment for aggressive B-cell non-Hodgkin lymphoma.
Am J Hematol
; 89(6): 639-45, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24633940
5.
Phase 2 trial of combined cisplatin, etoposide, gemcitabine, and methylprednisolone (PEGS) in peripheral T-cell non-Hodgkin lymphoma: Southwest Oncology Group Study S0350.
Cancer
; 119(2): 371-9, 2013 Jan 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22833464
6.
Impact of histological grading on survival in the SWOG S0016 follicular lymphoma cohort.
Haematologica
; 103(4): e151-e153, 2018 04.
Artigo
Inglês
| MEDLINE | ID: mdl-29472351
7.
Subclonal TP53 mutations are frequent and predict resistance to radioimmunotherapy in follicular lymphoma.
Blood Adv
; 7(17): 5082-5090, 2023 09 12.
Artigo
Inglês
| MEDLINE | ID: mdl-37379264
8.
Detection, prevalence, and duration of humoral responses to SARS-CoV-2 under conditions of limited population exposure.
medRxiv
; 2020 Aug 15.
Artigo
Inglês
| MEDLINE | ID: mdl-32817969
9.
Continued Excellent Outcomes in Previously Untreated Patients With Follicular Lymphoma After Treatment With CHOP Plus Rituximab or CHOP Plus 131I-Tositumomab: Long-Term Follow-Up of Phase III Randomized Study SWOG-S0016.
J Clin Oncol
; 36(7): 697-703, 2018 03 01.
Artigo
Inglês
| MEDLINE | ID: mdl-29356608
10.
Diffuse aggressive histologies of non-hodgkin lymphoma: treatment and biology of limited disease.
Semin Hematol
; 43(4): 207-12, 2006 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-17027654
11.
Phase II study of rituximab plus three cycles of CHOP and involved-field radiotherapy for patients with limited-stage aggressive B-cell lymphoma: Southwest Oncology Group study 0014.
J Clin Oncol
; 26(14): 2258-63, 2008 May 10.
Artigo
Inglês
| MEDLINE | ID: mdl-18413640
12.
Successful renal transplant outcome after intravenous gamma-globulin treatment of a highly sensitized pediatric recipient.
Pediatr Transplant
; 6(2): 161-5, 2002 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-12000474
13.
Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project.
Blood
; 103(11): 4251-8, 2004 Jun 01.
Artigo
Inglês
| MEDLINE | ID: mdl-14976040